A major challenge in the mechanistic understanding of HA in breast cancer-associated inflammation is to link HA metabolism with specific contributions of HA receptors CD44, RHAMM, and LYVE-1, which are all expressed by macrophages (78, 90–92). This evidence concerns the gene LYVE1 and breast cancer.